Krishna Institute of Medical Sciences Limited has informed the Exchange about Transcript
KIMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
KIMS Hospitals reported FY25 revenue of INR 3,067 crores, up 22% year-on-year, with EBITDA of INR 815 crores (24.7% growth) and margins expanding to 26.6% from 26%. PAT rose to INR 415 crores from INR 336 crores, and consolidated EPS reached INR 9.6, up 24%. Q4 FY25 revenue grew 25.7% YoY to INR 801 crores with EBITDA of INR 203 crores. New units (Nashik, Sangli, Kannur, Kollam, Guntur) contributed INR 111 crores but dragged EBITDA by INR 18 crores. Management guided Telangana cluster growth of 15-20% with mature cluster margins of 27-30%, while acknowledging group EBITDA margins will dip in FY26 due to fresh bed additions. Thane (Mumbai) soft-launched in April; two Bangalore hospitals targeted for July-August 2025 commissioning. CFO outlined net debt of INR 1,805 crores likely peaking around INR 2,100 crores, with capex of INR 600-700 crores over the next two years and a target net debt/EBITDA ratio of 1:2.
Strong FY25 print with margin expansion and clear multi-year capacity roadmap supports the growth story, though near-term group margins may compress as Thane and Bangalore hospitals ramp up. Investors should watch for new unit break-even timelines (12 months from commissioning) and debt-to-EBITDA trajectory as key checkpoints.